ArticleNature2023
Consent document translation expense hinders inclusive clinical trial enrolment.
Open access · greenAbstract read
In one paragraph
Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review.The oncologist · 2025Pooled it
- Representation of Hispanic Patients in Clinical Trials for Respiratory Failure: A Systematic Review.Critical care explorations · 2025Pooled it
- Physician- and Practice-Level Variation in Clinical Trial Participation Among Patients With Advanced Cancer.JAMA network open · 2026Article
- Language Barriers Limit Clinical Trial Accessibility for Patients With Gastrointestinal Cancer.Gastroenterology · 2026Article
- Consideration of Enrollment Rates of Asian, Asian Pacific Islander, and Hispanic Patients in Non-small Cell Lung Cancer Trials.Targeted oncology · 2026Article
- Moving together to facilitate equity and inclusion in research. The co-production of interventions for clinical trials to facilitate participation of people from ethnically diverse communities.Health research policy and systems · 2026Article
- Improving Informed Consent for English and Spanish Speakers in Clinical Trials.Therapeutic innovation & regulatory science · 2026Article
- Consent beyond the written form: Implications for ketamine trials in the Philippines.Therapeutic advances in psychopharmacology · 2026Article
- A cognitive screening program in community-based medical clinics to facilitate Latino participation in Alzheimer's disease research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Pharmacomicrobiomics.Clinical pharmacology and therapeutics · 2025Review
- Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity.BJC reports · 2025Review
- Demographic Trends in NCI-sponsored Early-phase Clinical Trials (2000-2023): A Cohort Study.Cancer discovery · 2025Article
- Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework.The oncologist · 2025Review
- Research coordinators' perspectives on recruitment of minoritized people with cystic fibrosis into clinical trials.BMC pulmonary medicine · 2025Article
- Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation.Journal of neurology · 2025Article
- Achieving Language Justice in Pediatric Hematology-Oncology: A Multinational Perspective for Language-Concordant Equitable Patient- and Family-Centered Care and Research Inclusion.Pediatric blood & cancer · 2025Review
- Researcher Perceptions of Inclusion of Study Participants Who Use Languages Other Than English.JAMA network open · 2025Article
- Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center.Frontiers in oncology · 2025Article
- Going beyond the technology: Considerations in translating electronic case report forms.Journal of clinical and translational science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 3 institutions in 1 country.
Maria A VelezDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-5197-4719
Beth A GlennJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Maria Garcia-JimenezDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Amy L CummingsDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0003-0472-392X
Aaron LisbergDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Andrea NañezDepartment of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
Yazeed RadwanDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Jackson P Lind-LebuffeDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Paige M BrodrickDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Debory Y LiDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Maria J Fernandez-TurizoDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Arjan GowerDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Maggie LindenbaumJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Manavi HegdeJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Jenny BrookDepartment of Medicine Statistics Core, University of California, Los Angeles, Los Angeles, CA, USA.
Tristan GroganDepartment of Medicine Statistics Core, University of California, Los Angeles, Los Angeles, CA, USA.
David ElashoffJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Michael A TeitellJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-4495-8750
Edward B GaronDepartment of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA. egaron@mednet.ucla.edu.ORCID 0000-0001-7077-8801
University of California, Los Angeles · USBeth Israel Deaconess Medical Center · USKaiser Permanente · US
Funding
Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5MUCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1MHLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapyR01CA276917 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EDWARD B GARON · 2023 to 2026
$2.9MIntratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLCK08CA245249 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LISBERG, AARON ELLIOTT · 2020 to 2024
$1.3MNCATS NIH HHS UL1 TR001881NCI NIH HHS K08 CA245249NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA276917
Abstract
Patients from historically under-represented racial and ethnic groups are enrolled in cancer clinical trials at disproportionately low rates in the USA
Indexed as
Clinical Trials as TopicCommunication BarriersConsent FormsDrug IndustryResearch PersonnelTranslationsHumansTranslating
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.